Table 7: Acute Flare and Long-term Management Therapies in Cats

Download a PDF of Table 7

Drug Name

Acute Flare

Long-term Management

Advantage/Disadvantage

Corticosteroids

  • Rapid onset of action
  • Side effects common

Cyclosporine

X

  • Does not interfere with intradermal allergy testing
  • Slow onset of action (weeks)
  • Side effects common (gastrointestinal, hypersalivation, lethargy, gingival hyperplasia)
  • Requires periodic monitoring of hepatic enzymes and blood cell counts

Allergen-specific immunotherapy

X

  • Safe to use in combination with other medications
  • Only management strategy that induces change in the immune response
  • Biologic compound
  • Slow onset of action (months to 1 yr)
  • Requires intradermal or serum allergy testing

EFAs

X

  • May have steroid-sparing benefits
  • Slow onset of action (weeks to months)

Antihistamines

X

  • Side effects uncommon
  • Questionable efficacy—may only be effective in mildly pruritic animals

EFAs, essential fatty acids.

Note: Oclacitinib is not labeled for use in cats. Lokivetmab is contraindicated in cats.


The 2023 AAHA Management of Allergic Skin Diseases in Dogs and Cats Guidelines are generously supported by Hill’s Pet Nutrition, Merck Animal Health, and Zoetis.

Hill's Pet Nutrition
merck.png
Zoetis